Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA's Approval of Waskyra
Published 5 months, 1 week ago
Description
In today’s Pharmaceutical Executive Daily, new analysis outlines what it may truly cost to fix the biopharma ecosystem, the FDA approves Waskyra for patients with Wiskott-Aldrich syndrome, and OTR Therapeutics enters a strategic collaboration with Zealand to develop novel metabolic disease therapies.